Reminder: Maine Research Symposium on Biomedical Science and Engineering rescheduled for March 27-28
The second Maine Research Symposium on Biomedical Science and Engineering has been rescheduled for Wednesday and Thursday, March 27-28, in the Wells Conference Center at the University of Maine.
Originally scheduled for Oct. 25-27, the symposium was cut short Oct. 26 in response to the mass shooting in Lewiston. On the event’s first day, participants were able to attend various sessions on mental health, including keynote lectures on Alzheimer’s disease and mental health research in Maine; panels on substance abuse, autism, racial disparities, moral injury, liver dysfunction and sleep disorders; and a poster session with over 70 entries from professional and student researchers.
On March 27, the symposium will resume with lectures about oncology and translational medicine, as well as a panel discussion on workforce development, microscopy, cell signaling, kidney and pathogens. UMaine students and others will also present posters highlighting their undergraduate and graduate research in biomedical sciences.
Sessions for March 28 will include clinical research, rural/public health, artificial intelligence applications in medicine, engineering approaches, cellular mechanisms with disease states and age-related disease states. The Maine Rural Graduate Medical Education (MERGE) Collaborative’s first Rural GME Conference will also take place on March 28, and explore various topics to support physicians, interprofessional educators and clinicians, administrators and others from across the state who are interested in improving, supporting and utilizing graduate medical education.
Visit the Symposium website for more information and updates.
“We are grateful to the speakers, panelists and other participants who were supportive of our decision to cancel the last two days of the symposium and are now putting all their efforts into the rescheduled event,” says David Harder, director of the UMaine Institute of Medicine.
The organizing committee includes the Institute of Medicine, the Jackson Laboratory (JAX), MDI Biological Laboratory, MaineHealth, Northern Light Health, the University of New England, the University of Southern Maine, the Roux Institute at Northeastern University and the MERGE Collaborative.